VCT220
A Research Study of VCT220 in Adult Chinese Participants With Obesity
Vincentage Pharma Co · Phase 3 · Completed · Enrollment 840
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| High dose group | n/r | n/r | n/r | n/r | n/r |
| Moderate dose group | n/r | n/r | n/r | n/r | n/r |
| Placebo group | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.